Does ALEMTUZUMAB Cause Dysarthria? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Dysarthria have been filed in association with ALEMTUZUMAB (Campath). This represents 0.7% of all adverse event reports for ALEMTUZUMAB.
102
Reports of Dysarthria with ALEMTUZUMAB
0.7%
of all ALEMTUZUMAB reports
5
Deaths
64
Hospitalizations
How Dangerous Is Dysarthria From ALEMTUZUMAB?
Of the 102 reports, 5 (4.9%) resulted in death, 64 (62.7%) required hospitalization, and 10 (9.8%) were considered life-threatening.
Is Dysarthria Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Dysarthria?
OLANZAPINE (900)
QUETIAPINE (669)
PREGABALIN (618)
AMLODIPINE (553)
GABAPENTIN (548)
METFORMIN (540)
METHOTREXATE (536)
DIAZEPAM (512)
ASPIRIN (495)
LORAZEPAM (483)
Which ALEMTUZUMAB Alternatives Have Lower Dysarthria Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET